AMIT KUMAR - 30 Oct 2025 Form 4 Insider Report for Anixa Biosciences Inc (ANIX)

Role
Chief Executive Officer
Signature
/s/ Amit Kumar
Issuer symbol
ANIX
Transactions as of
30 Oct 2025
Transactions value $
-$103,922
Form type
4
Filing time
31 Oct 2025, 09:13:33 UTC
Previous filing
31 Jul 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
KUMAR AMIT Chief Executive Officer C/O ANIXA BIOSCIENCES, INC., 3150 ALMADEN EXPRESSWAY, SUITE 250, SAN JOSE, /s/ Amit Kumar 31 Oct 2025 0001191905

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ANIX Common Stock Options Exercise $584K +200K +34.49% $2.92 780K 30 Oct 2025 Direct
transaction ANIX Common Stock Tax liability -$688K -169K -21.73% $4.06 610K 30 Oct 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ANIX Employee Stock Option (Right to Buy) Options Exercise $0 -200K -100% $0.00 0 30 Oct 2025 Common Stock 200K $2.92 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reporting person exercised the stock options at this time due to their upcoming expiration on February 18, 2026. The disposal of shares reported herein represents shares withheld by Anixa Biosciences, Inc. (the "registrant") to (i) cover the exercise price of the stock options and (ii) satisfy tax withholding obligations in connection with the exercise of the stock options. Dr. Kumar did not sell any shares in connection with the exercise of the options.
F2 Right-To-Buy, pursuant to a stock option grant dated February 18, 2016.
F3 The option vested in 36 consecutive monthly installments beginning on March 31, 2016.